Quantum Private Wealth’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,252
Closed -$74.9K 184
2025
Q2
$74.9K Sell
10,252
-2,624
-20% -$21.2K 0.02% 167
2025
Q1
$122K Hold
12,876
0.05% 159
2024
Q4
$212K Hold
12,876
0.07% 170
2024
Q3
$190K Hold
12,876
0.06% 178
2024
Q2
$179K Hold
12,876
0.06% 176
2024
Q1
$202K Hold
12,876
0.08% 168
2023
Q4
$208K Hold
12,876
0.09% 169
2023
Q3
$158K Hold
12,876
0.08% 169
2023
Q2
$207K Hold
12,876
0.1% 167
2023
Q1
$224K Hold
12,876
0.12% 165
2022
Q4
$119K Hold
12,876
0.08% 164
2022
Q3
$110K Hold
12,876
0.07% 166
2022
Q2
$104K Hold
12,876
0.06% 170
2022
Q1
$156K Hold
12,876
0.07% 189
2021
Q4
$439K Buy
+12,876
New +$504K 0.17% 121

Other funds holding NEO

Quantum Private Wealth's NEO Position: Q3 2025 in Review

Quantum Private Wealth sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 10,252 shares — an estimated $74.9K sold.

Quantum Private Wealth first reported a position in NEO in Q4 2021 and held it in 15 quarters. The position peaked at $439K in Q4 2021. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Quantum Private Wealth reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Quantum Private Wealth sold 10,252 NeoGenomics shares in Q3 2025, an estimated $74.9K.
  • Quantum Private Wealth first reported a position in NeoGenomics in Q4 2021 and held it in 15 quarters.
  • Quantum Private Wealth's NeoGenomics position peaked at $439K in Q4 2021.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Quantum Private Wealth's 13F filing for Q3 2025, filed 10 Nov 2025.